Efficacy and Safety Study of Oral BG00012 With Active Reference in Relapsing-Remitting Multiple Sclerosis

NCT00451451 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1417

Enrollment

INDUSTRY

Sponsor class

Conditions

Relapsing-Remitting Multiple Sclerosis

Interventions

DRUG: BG00012
DRUG: Placebo
DRUG: Glatiramer Acetate

Sponsor

Biogen